Publication | Closed Access

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

PsychiatryMedicinePsychotropic MedicationPsychopharmacologySchizophreniaNeuropharmacologyPlacebo-controlled TrialPharmacotherapyPharmacologySodium BenzoatePsychotic Disorder